Looks like you’re on the US site. Choose another location to see content specific to your location

Home Animal Health Dechra backs Senior Dog Society for canine geriatric CE push
NEWS & BLOGS IMAGES (85)

Dechra backs Senior Dog Society for canine geriatric CE push

18th November 2026

Dechra has signed a strategic partnership with the Senior Dog Veterinary Society (SDVS) to build a US-focused geriatric canine education and certification programme, with rollout targeted at the 2027 VMX and Western Veterinary Conference events. Announced on 10 November 2026 during National Senior Pet Month, the deal gives Dechra’s specialty care portfolio a dedicated education channel inside a category where more than half of US dog-owning households already keep a senior dog. For commercial leaders in companion animal pharmaceuticals, the move is a textbook pull strategy aimed at the chronic disease prescribing conversation.

The geriatric category is where portfolio meets volume

Dechra’s portfolio reads as a geriatric formulary. Canine hyperadrenocorticism, feline hyperthyroidism, dermatologic disorders, lymphoma, dental disease, musculoskeletal pain, and anaesthesia and sedation protocols for older surgical patients all map onto the senior pet consultation. Monica Tarantino, SDVS co-founder, explained the demand side: “many veterinarians never received dedicated geriatrics training in vet school.” That gap is what the partnership addresses, through continuing education modules covering patient assessment, treatment planning and owner communication, together with repeatable clinical approaches to early detection, chronic disease management, mobility, pain control and quality of life. Tara Bidgood, vice president of professional services and medical affairs at Dechra, framed the intent broadly: pets deserve “exceptional care throughout their entire lives.”

The commercial logic is direct. Chronic disease management means long therapy durations, repeat prescriptions and higher lifetime revenue per patient than acute care. A vet trained to screen proactively for Cushing’s, hyperthyroidism or progressive osteoarthritis will initiate more treatment courses, earlier, and keep more patients on therapy. Education that shifts clinical practice toward proactive geriatric screening expands the addressable market without any direct product spend.

Certification as a commercial moat

Senior pet veterinarian certification at VMX and WVC in 2027 is the visible rollout, but the deeper play is the KOL network Dechra is building. Certified vets become category advocates with branded educational material behind them, tying clinical identity to the Dechra professional services infrastructure. Replacing such a network takes years and significant investment, which is why certification programmes tend to anchor prescribing patterns well beyond the enrolment window.

The US focus is pragmatic: the article cites that more than half of US dog-owning households own a senior dog, and the chosen conference channels, VMX and WVC, are the two largest US veterinary continuing education events. Expect follow-on partnerships and European expansion in 2027, particularly through UK and EU specialty vet networks.

Hiring implications across the specialty care channel

Dechra’s professional services and medical affairs function tightens first. Veterinary technical consultants with geriatric endocrinology, oncology, pain or dermatology credentials are the obvious commercial need, and the overlap with SDVS-certified vets will narrow supply further. CE programme managers, scientific writers for geriatric content and KOL managers for the certified-vet network round out the immediate expansion. On the field side, territory sales reps carrying endocrinology or pain portfolios into senior-weighted practices will be hired or redeployed to match the VMX and WVC rollout cadence.

Geriatric canine care is becoming a defined commercial category rather than a cohort of unconnected indications, and Dechra has positioned itself as the professional services anchor for it. Through 2027, expect clearer segmentation between generalist companion animal portfolios and specialty-care-led ones, with the certification channel acting as the differentiator. The commercial centre of companion animal pharmaceuticals is moving toward chronic disease, and the education infrastructure around it is where the next margin layer gets built.

For the latest updates and in-depth insights into the world of Animal Health, including breakthrough treatments, industry trends, and regulatory news, contact Albert Baines today! 

Stay informed

Receive the latest industry news, Tips and straight to your inbox.

wpChatIcon
wpChatIcon